BUSINESS ACQUISITIONS (Tables)

9 Months Ended

Dec. 26, 2020

Business Acquisition [Line Items]

Schedule of Proforma Information

The results of acquired businesses are included in Transcat’s consolidated operating results as of the dates the businesses were acquired. The following unaudited pro forma information presents the Company’s results of operations as if the acquisition of pipettes.com and BioTek had occurred at the beginning of fiscal year 2020. The pro forma results do not purport to represent what the Company’s results of operations actually would have been if the transaction had occurred at the beginning of the period presented or what the Company’s operating results will be in future periods.

13

	(Unaudited)		(Unaudited)
	Nine Months Ended		Nine Months Ended
	December 26, 2020		December 28, 2019
Total Revenue	$	126,121	$	135,115
Net Income	$	4,843	$	6,493
Basic Earnings Per Share	$	0.65	$	0.89
Diluted Earnings Per Share	$	0.64	$	0.87

BioTek Services, Inc. [Member]

Business Acquisition [Line Items]

Schedule of Purchase Price Allocation

The total purchase price paid for the assets of BioTek was approximately $3.4 million. $0.4 million of the purchase price has been put into escrow as a holdback for indemnification claims, if any. The following is a preliminary summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of BioTek’s assets and liabilities acquired during the period presented:

		FY 2021
Goodwill		$	1,927
Intangible Assets – Customer Base & Contracts			1,066
Intangible Assets – Covenant Not to Compete			100
			3,093
Plus:	Current Assets		406
	Non-Current Assets		8
Less:	Current Liabilities		(60	)
Total Purchase Price		$	3,447

TTE Laboratories, Inc. [Member]

Business Acquisition [Line Items]

Schedule of Purchase Price Allocation

The total purchase price paid for the assets of pipettes.com was approximately $12.2 million. $1.2 million of the purchase price has been put into escrow as a holdback for indemnification claims, if any. The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of pipettes.com assets and liabilities acquired during the period presented:

		FY 2021
Goodwill		$	6,751
Intangible Assets – Customer Base & Contracts			4,410
Intangible Assets – Covenant Not to Compete			120
			11,281
Plus:	Current Assets		928
	Non-Current Assets		261
Less:	Current Liabilities		(239	)
Total Purchase Price		$	12,231